Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Gossamer Bio (GOSS) Accounts Payables: 2022-2024

Historic Accounts Payables for Gossamer Bio (GOSS) over the last 3 years, with Dec 2024 value amounting to $2.3 million.

  • Gossamer Bio's Accounts Payables fell 63.49% to $1.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.1 million, marking a year-over-year decrease of 63.49%. This contributed to the annual value of $2.3 million for FY2024, which is 58.03% down from last year.
  • Gossamer Bio's Accounts Payables amounted to $2.3 million in FY2024, which was down 58.03% from $5.5 million recorded in FY2023.
  • In the past 5 years, Gossamer Bio's Accounts Payables registered a high of $5.5 million during FY2023, and its lowest value of $1.5 million during FY2022.
  • In the last 3 years, Gossamer Bio's Accounts Payables had a median value of $2.3 million in 2024 and averaged $3.1 million.
  • In the last 5 years, Gossamer Bio's Accounts Payables skyrocketed by 278.75% in 2023 and then plummeted by 58.03% in 2024.
  • Over the past 3 years, Gossamer Bio's Accounts Payables (Yearly) stood at $1.5 million in 2022, then soared by 278.75% to $5.5 million in 2023, then slumped by 58.03% to $2.3 million in 2024.